Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs

Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs

US Patent 7001619 · Granted Feb 21, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid dispersion comprising an anticancer compound for improved solubility and e2024
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitor2020
Lubricant formulation of carbamoylethyl katira and a process for preparation the2020
1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the2018
Rohitukine analogs as cyclin-dependent kinase inhibitors and a process for the p2018
10-substituted colchicinoids as potent anticancer agents2018
Chalcones as enhancer of antimicrobial agents2015
Aromatic amides as potentiators of bioefficacy of anti-infective drugs2015
Aromatic amides as potentiators of bioefficacy of anti-infective drugs2015
2-anilino nicotinyl linked 2-amino benzothiazole conjugates and process for the 2015
Aromatic amides as potentiators of bioefficacy of anti-infective drugs2013
Aromatic amides as potentiators of bioefficacy of anti-infective drugs2013